Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies.

A. Pertzelan, R. Keret, B. Bauman, Z. Ben-Zeev, D. B. Olsen, B. Szoke, A. M. Comaru-Schally, Andrew V Schally, Z. Laron

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

52 patients (42 children and 10 adults) with growth hormone deficiency (GHD), grouped into four diagnostic categories, and 6 children with constitutional short stature who served as controls were tested for plasma GH response to synthetic GH-RH1-44 given in an intravenous bolus. The response was classified into three degrees according to the magnitude of the maximal rise: Good, greater than 9 ng/ml; Partial, 3.1-9.0 ng/ml; None, less than or equal to 3 ng/ml. Among the GHD patients the highest response was observed in patients with partial growth hormone deficiency (PGHD), and 60% of the children with isolated GH deficiency (IGHD) showed an increase in plasma GH levels. Nevertheless, the response of the GHD patients was lower than that in the control group. In the children and adolescents with PGHD and IGHD the response was not age related. Among those with multiple pituitary hormone deficiencies-idiopathic (MPHD-ID) there was no response in the adolescents although a hypothalamic disorder had been documented by other tests. Among those with MPHD-organic (MPHD-ORG) the GH-RH stimulated GH secretion in the patients with glioma, who had received only irradiation treatment, and in the youngest of the patients with craniopharyngioma. Of the 10 young adults tested none showed a good response. It is concluded that GH-RH is useful in differentiating between GH deficiency of hypothalamic origin and that of pituitary origin, and in selecting those patients who might benefit from long-term treatment with GH-RH in the future.

Original languageEnglish
Pages (from-to)24-31
Number of pages8
JournalHormone Research
Volume22
Issue number1-2
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Growth Hormone
Pituitary Dwarfism
Craniopharyngioma
Pituitary Hormones
Glioma
Young Adult
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Pertzelan, A., Keret, R., Bauman, B., Ben-Zeev, Z., Olsen, D. B., Szoke, B., ... Laron, Z. (1985). Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies. Hormone Research, 22(1-2), 24-31.

Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies. / Pertzelan, A.; Keret, R.; Bauman, B.; Ben-Zeev, Z.; Olsen, D. B.; Szoke, B.; Comaru-Schally, A. M.; Schally, Andrew V; Laron, Z.

In: Hormone Research, Vol. 22, No. 1-2, 01.01.1985, p. 24-31.

Research output: Contribution to journalArticle

Pertzelan, A, Keret, R, Bauman, B, Ben-Zeev, Z, Olsen, DB, Szoke, B, Comaru-Schally, AM, Schally, AV & Laron, Z 1985, 'Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies.', Hormone Research, vol. 22, no. 1-2, pp. 24-31.
Pertzelan, A. ; Keret, R. ; Bauman, B. ; Ben-Zeev, Z. ; Olsen, D. B. ; Szoke, B. ; Comaru-Schally, A. M. ; Schally, Andrew V ; Laron, Z. / Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies. In: Hormone Research. 1985 ; Vol. 22, No. 1-2. pp. 24-31.
@article{6ee0d07c676f4449af434a6867e24da0,
title = "Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies.",
abstract = "52 patients (42 children and 10 adults) with growth hormone deficiency (GHD), grouped into four diagnostic categories, and 6 children with constitutional short stature who served as controls were tested for plasma GH response to synthetic GH-RH1-44 given in an intravenous bolus. The response was classified into three degrees according to the magnitude of the maximal rise: Good, greater than 9 ng/ml; Partial, 3.1-9.0 ng/ml; None, less than or equal to 3 ng/ml. Among the GHD patients the highest response was observed in patients with partial growth hormone deficiency (PGHD), and 60{\%} of the children with isolated GH deficiency (IGHD) showed an increase in plasma GH levels. Nevertheless, the response of the GHD patients was lower than that in the control group. In the children and adolescents with PGHD and IGHD the response was not age related. Among those with multiple pituitary hormone deficiencies-idiopathic (MPHD-ID) there was no response in the adolescents although a hypothalamic disorder had been documented by other tests. Among those with MPHD-organic (MPHD-ORG) the GH-RH stimulated GH secretion in the patients with glioma, who had received only irradiation treatment, and in the youngest of the patients with craniopharyngioma. Of the 10 young adults tested none showed a good response. It is concluded that GH-RH is useful in differentiating between GH deficiency of hypothalamic origin and that of pituitary origin, and in selecting those patients who might benefit from long-term treatment with GH-RH in the future.",
author = "A. Pertzelan and R. Keret and B. Bauman and Z. Ben-Zeev and Olsen, {D. B.} and B. Szoke and Comaru-Schally, {A. M.} and Schally, {Andrew V} and Z. Laron",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "22",
pages = "24--31",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "1-2",

}

TY - JOUR

T1 - Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies.

AU - Pertzelan, A.

AU - Keret, R.

AU - Bauman, B.

AU - Ben-Zeev, Z.

AU - Olsen, D. B.

AU - Szoke, B.

AU - Comaru-Schally, A. M.

AU - Schally, Andrew V

AU - Laron, Z.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - 52 patients (42 children and 10 adults) with growth hormone deficiency (GHD), grouped into four diagnostic categories, and 6 children with constitutional short stature who served as controls were tested for plasma GH response to synthetic GH-RH1-44 given in an intravenous bolus. The response was classified into three degrees according to the magnitude of the maximal rise: Good, greater than 9 ng/ml; Partial, 3.1-9.0 ng/ml; None, less than or equal to 3 ng/ml. Among the GHD patients the highest response was observed in patients with partial growth hormone deficiency (PGHD), and 60% of the children with isolated GH deficiency (IGHD) showed an increase in plasma GH levels. Nevertheless, the response of the GHD patients was lower than that in the control group. In the children and adolescents with PGHD and IGHD the response was not age related. Among those with multiple pituitary hormone deficiencies-idiopathic (MPHD-ID) there was no response in the adolescents although a hypothalamic disorder had been documented by other tests. Among those with MPHD-organic (MPHD-ORG) the GH-RH stimulated GH secretion in the patients with glioma, who had received only irradiation treatment, and in the youngest of the patients with craniopharyngioma. Of the 10 young adults tested none showed a good response. It is concluded that GH-RH is useful in differentiating between GH deficiency of hypothalamic origin and that of pituitary origin, and in selecting those patients who might benefit from long-term treatment with GH-RH in the future.

AB - 52 patients (42 children and 10 adults) with growth hormone deficiency (GHD), grouped into four diagnostic categories, and 6 children with constitutional short stature who served as controls were tested for plasma GH response to synthetic GH-RH1-44 given in an intravenous bolus. The response was classified into three degrees according to the magnitude of the maximal rise: Good, greater than 9 ng/ml; Partial, 3.1-9.0 ng/ml; None, less than or equal to 3 ng/ml. Among the GHD patients the highest response was observed in patients with partial growth hormone deficiency (PGHD), and 60% of the children with isolated GH deficiency (IGHD) showed an increase in plasma GH levels. Nevertheless, the response of the GHD patients was lower than that in the control group. In the children and adolescents with PGHD and IGHD the response was not age related. Among those with multiple pituitary hormone deficiencies-idiopathic (MPHD-ID) there was no response in the adolescents although a hypothalamic disorder had been documented by other tests. Among those with MPHD-organic (MPHD-ORG) the GH-RH stimulated GH secretion in the patients with glioma, who had received only irradiation treatment, and in the youngest of the patients with craniopharyngioma. Of the 10 young adults tested none showed a good response. It is concluded that GH-RH is useful in differentiating between GH deficiency of hypothalamic origin and that of pituitary origin, and in selecting those patients who might benefit from long-term treatment with GH-RH in the future.

UR - http://www.scopus.com/inward/record.url?scp=0021778883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021778883&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 24

EP - 31

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 1-2

ER -